{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:48:12Z","timestamp":1790639292899,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.lfs.2021.119076","type":"journal-article","created":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T23:55:02Z","timestamp":1610927702000},"page":"119076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Down-regulation of MALAT1 aggravates polycystic ovary syndrome by regulating MiR-302d-3p-mediated leukemia inhibitory factor activity"],"prefix":"10.1016","volume":"277","author":[{"given":"Yafei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119076_bb0005","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-016-0173-x","article-title":"Genetic, hormonal and metabolic aspects of PCOS: an update","volume":"14","author":"De Leo","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119076_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","article-title":"Treatment strategies for women with polycystic ovary syndrome","volume":"34","author":"Jin","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119076_bb0015","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney Ch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.119076_bb0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1590\/1806-9282.62.09.867","article-title":"Current aspects of polycystic ovary syndrome: a literature review","volume":"62","author":"Andrade","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.lfs.2021.119076_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110611","article-title":"Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS)","volume":"500","author":"Makrinou","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119076_bb0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2011.03.014","article-title":"No-nonsense functions for long noncoding RNAs","volume":"145","author":"Nagano","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119076_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/cen.14087","article-title":"Alterations in long noncoding RNAs in women with and without polycystic ovarian syndrome","volume":"91","author":"Butler","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119076_bb0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15476286.2017.1358347","article-title":"The long noncoding RNA Malat1: its physiological and pathophysiological functions","volume":"14","author":"Zhang","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.lfs.2021.119076_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110589","article-title":"MALAT1 is involved in the pathophysiological process of PCOS by modulating TGFbeta signaling in granulosa cells","volume":"499","author":"Zhang","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2021.119076_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.082","article-title":"The role of MiRNA in polycystic ovary syndrome (PCOS)","volume":"706","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2021.119076_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2013.11.023","article-title":"MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1","volume":"345","author":"Yan","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2021.119076_bb0060","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/en.2017-00605","article-title":"Long noncoding RNAs: potential regulators involved in the pathogenesis of polycystic ovary syndrome","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2021.119076_bb0065","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1080\/15384101.2019.1652036","article-title":"Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19","volume":"18","author":"Wang","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lfs.2021.119076_bb0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.omtn.2019.08.010","article-title":"Exosomes derived from miR-143-overexpressing MSCs inhibit cell migration and invasion in human prostate cancer by downregulating TFF3","volume":"18","author":"Che","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.lfs.2021.119076_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2018.03.002","article-title":"Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing","volume":"657","author":"Fu","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2021.119076_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2019.00116","article-title":"Metabolomics of dynamic changes in insulin resistance before and after exercise in PCOS","volume":"10","author":"Halama","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.lfs.2021.119076_bb0085","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.lfs.2021.119076_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119076_bb0095","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2147\/OTT.S154517","article-title":"MicroRNA 302b-3p\/302c-3p\/302d-3p inhibits epithelial-mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.lfs.2021.119076_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2021.119076_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/GMIT.GMIT_112_18","article-title":"Evaluation of endometrial receptivity by measuring HOXA-10, HOXA-11, and leukemia inhibitory factor expression in patients with polycystic ovary syndrome","volume":"8","author":"Kara","year":"2019","journal-title":"Gynecol Minim Invasive Ther"},{"key":"10.1016\/j.lfs.2021.119076_bb0110","first-page":"61","article-title":"miR-302b-3p promotes self-renewal properties in leukemia inhibitory factor-withdrawn embryonic stem cells","volume":"20","author":"Moradi","year":"2018","journal-title":"Cell J."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:47:45Z","timestamp":1758401265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":22,"alternative-id":["S0024320521000618"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119076","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-regulation of MALAT1 aggravates polycystic ovary syndrome by regulating MiR-302d-3p-mediated leukemia inhibitory factor activity","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119076"}}